Amundi’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Buy |
99,161
+93,189
| +1,560% | +$3.68M | ﹤0.01% | 965 |
|
|
2025
Q1 | $210K | Hold |
5,972
| – | – | ﹤0.01% | 1667 |
|
|
2024
Q4 | $261K | Hold |
5,972
| – | – | ﹤0.01% | 1684 |
|
|
2024
Q3 | $318K | Buy |
5,972
+2,034
| +52% | +$108K | ﹤0.01% | 1535 |
|
|
2024
Q2 | $158K | Sell |
3,938
-15,712
| -80% | -$632K | ﹤0.01% | 1621 |
|
|
2024
Q1 | $852K | Sell |
19,650
-75,288
| -79% | -$3.27M | ﹤0.01% | 1314 |
|
|
2023
Q4 | $4.59M | Sell |
94,938
-33,054
| -26% | -$1.6M | ﹤0.01% | 1001 |
|
|
2023
Q3 | $4.3M | Hold |
127,992
| – | – | ﹤0.01% | 1015 |
|
|
2023
Q2 | $5.97M | Buy |
127,992
+90,062
| +237% | +$4.2M | ﹤0.01% | 946 |
|
|
2023
Q1 | $1.47M | Sell |
37,930
-714
| -2% | -$27.7K | ﹤0.01% | 1202 |
|
|
2022
Q4 | $1.61M | Buy |
38,644
+32,286
| +508% | +$1.35M | ﹤0.01% | 1233 |
|
|
2022
Q3 | $258K | Buy |
+6,358
| New | +$258K | ﹤0.01% | 1425 |
|